Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Jan 19;103(2):129-42.
doi: 10.1093/jnci/djq455. Epub 2010 Nov 16.

Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis

Yan Xing  1 , Yulia Bronstein, Merrick I Ross, Robert L Askew, Jeffrey E Lee, Jeffrey E Gershenwald, Richard Royal, Janice N Cormier
Affiliations
Meta-Analysis

Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis

Yan Xing et al. J Natl Cancer Inst. .

Abstract

Background: Meta-analyses were performed to examine the utility of ultrasonography, computed tomography (CT), positron emission tomography (PET), and a combination of both (PET-CT) for the staging and surveillance of melanoma patients.

Method: Patient-level data from 74 studies containing 10,528 patients (between January 1, 1990, and June, 30, 2009) were used to derive characteristics of the diagnostic tests used. Meta-analyses were conducted by use of Bayesian bivariate binomial models to estimate sensitivity and specificity. Diagnostic odds ratios [ie, true-positive results/false-negative results)/(false-positive results/true-negative results)] and their 95% credible intervals (CrIs) and positive predictive values were used as indicators of test performance.

Results: Among the four imaging methods examined for the staging of regional lymph nodes, ultrasonography had the highest sensitivity (60%, 95% CrI = 33% to 83%), specificity (97%, 95% CrI = 88% to 99%), and diagnostic odds ratio (42, 95% CrI = 8.08 to 249.8). For staging of distant metastases, PET-CT had the highest sensitivity (80%, 95% CrI = 53% to 93%), specificity (87%, 95% CrI = 54% to 97%), and diagnostic odds ratio (25, 95% CrI = 3.58 to 198.7). Similar trends were observed for melanoma surveillance of lymph node involvement, with ultrasonography having the highest sensitivity (96%, 95% CrI = 85% to 99%), specificity (99%, 95% CrI = 95% to 100%), and diagnostic odds ratio (1675, 95% CrI = 226.6 to 15,920). For distant metastases, PET-CT had the highest sensitivity (86%, 95% CrI = 76% to 93%), specificity (91%, 95% CrI = 79% to 97%), and diagnostic odds ratio (67, 95% CrI = 20.42 to 229.7). Positive predictive values were likewise highest for ultrasonography in lymph node staging and for PET-CT in detecting distant metastases.

Conclusion: Among the compared modalities, ultrasonography was superior for detecting lymph node metastases, and PET-CT was superior for the detection of distant metastases in both the staging and surveillance of melanoma patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram of the Distribution of Quality Assessment of Diagnostic Accuracy Studies (QUADAS) scores for diagnostic studies (n = 74).
Figure 2
Figure 2
Forest plots of the test characteristics of four diagnostic modalities. A) Forest plots for sensitivity and specificity for ultrasonography (US), computed tomography (CT), positron emission tomography (PET), and PET-CT for the clinical scenarios indicated. B) Forest plots for diagnostic odds ratio for ultrasonography (US), computed tomography (CT), positron emission tomography (PET), and PET-CT for the clinical scenarios indicated. The squares represent the median and the whiskers represent the 95% credible interval.
Figure 3
Figure 3
Funnel plot for diagnostic odds ratio (dOR) with standard error. A) Ultrasonography (US). B) Computed tomography (CT). C) Positron emission tomography (PET). D) PET-CT. Data from each modality are plotted against their standard error (SE). Solid line = summary estimate of the dOR; dashed line = 95% confidence limits around the dOR.
See this image and copyright information in PMC

References

    1. American Joint Committee on Cancer. New York, NY: Springer; 2009. Melanoma of the Skin; pp. 325–344. In: Edge SB, Byrd DR, Compton CC, et al. eds. AJCC Cancer Staging Manual. 7th ed.
    1. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician_gls/def/ault.asp.
    1. Aloia TA, Gershenwald JE, Andtbacka RH, et al. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol. 2006;24(18):2858–2865. - PubMed
    1. Balch CM, Cascinelli N. Sentinel-node biopsy in melanoma. N Engl J Med. 2006;355(13):1370–1371. - PubMed
    1. Sanki A, Uren RF, Moncrieff M, et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol. 2009;27(33):5614–5619. - PubMed

Publication types